Study to Evaluate Imatinib in Desmoid Tumors

Conditions:   Aggressive Fibromatosis;   Desmoid TumorIntervention:   Drug: ImatinibSponsors:   Heidelberg University;   NovartisActive, not recruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fibroma | Gleevec | Research | Study